Literature DB >> 21225593

Involvement of ADAMTS5 and hyaluronidase in aggrecan degradation and release from OSM-stimulated cartilage.

M Durigova1, L Troeberg, H Nagase, P J Roughley, J S Mort.   

Abstract

The relative contribution of a disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS)4 and ADAMTS5 to aggrecan degradation under oncostatin M (OSM) stimulation, the role of the ancillary domains of the aggrecanases on their ability to cleave within the chondroitin sulfate (CS)-2 region, the role of hyaluronidases (HYAL) in stimulating aggrecan release in the absence of proteolysis, and the identity of the hyaluronidase involved in OSM-mediated cartilage breakdown were investigated. Bovine articular cartilage explants were cultured in the presence of interleukin-1beta (IL-1beta), tumor necrosis factor alpha (TNFalpha) and/or OSM, or treated with trypsin and/or hyaluronidase. Aggrecan was digested with various domain-truncated isoforms of ADAMTS4 and ADAMTS5. Aggrecan and link protein degradation and release were analyzed by immunoblotting. Aggrecanase and HYAL gene expression were determined. ADAMTS4 was the most inducible aggrecanase upon cytokine stimulation, whereas ADAMTS5 was the most abundant aggrecanase. ADAMTS5 was the most active aggrecanase and was responsible for the generation of an OSM-specific degradation pattern in the CS-2 region. Its ability to cleave at the OSM-specific site adjacent to the aggrecan G3 region was enhanced by truncation of the C-terminal thrombospondin domain, but reduced by further truncation of both the spacer and cysteine-rich domains of the enzyme. OSM has the ability to mediate proteoglycan release through hyaluronan degradation, under conditions where HYAL-2 is the predominant hyaluronidase being expressed. Compared to other catabolic cytokines, OSM exhibits a unique potential at degrading the proteoglycan aggregate, by promoting early robust aggrecanolysis, primarily through the action of ADAMTS5, and hyaluronan degradation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21225593      PMCID: PMC3249595          DOI: 10.22203/ecm.v021a03

Source DB:  PubMed          Journal:  Eur Cell Mater        ISSN: 1473-2262            Impact factor:   3.942


  49 in total

1.  The C-type lectin domains of lecticans, a family of aggregating chondroitin sulfate proteoglycans, bind tenascin-R by protein-protein interactions independent of carbohydrate moiety.

Authors:  A Aspberg; R Miura; S Bourdoulous; M Shimonaka; D Heinegârd; M Schachner; E Ruoslahti; Y Yamaguchi
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-16       Impact factor: 11.205

Review 2.  Aggrecan, aging and assembly in articular cartilage.

Authors:  J Dudhia
Journal:  Cell Mol Life Sci       Date:  2005-10       Impact factor: 9.261

Review 3.  The six hyaluronidase-like genes in the human and mouse genomes.

Authors:  A B Csoka; G I Frost; R Stern
Journal:  Matrix Biol       Date:  2001-12       Impact factor: 11.583

4.  Cartilage degradation independent of MMP/aggrecanases.

Authors:  Kotaro Sugimoto; Tomoko Iizawa; Hosami Harada; Kazuyo Yamada; Mutsumi Katsumata; Masaaki Takahashi
Journal:  Osteoarthritis Cartilage       Date:  2004-12       Impact factor: 6.576

5.  Hyaluronate degradation as an alternative mechanism for proteoglycan release from cartilage during interleukin-1beta-stimulated catabolism.

Authors:  Robert Sztrolovics; Anneliese D Recklies; Peter J Roughley; John S Mort
Journal:  Biochem J       Date:  2002-03-01       Impact factor: 3.857

6.  The mechanism of aggrecan release from cartilage differs with tissue origin and the agent used to stimulate catabolism.

Authors:  Robert Sztrolovics; Robert J White; Peter J Roughley; John S Mort
Journal:  Biochem J       Date:  2002-03-01       Impact factor: 3.857

7.  The properties of proteoglycan prepared from human articular cartilage by using associative caesium chloride gradients of high and low starting densities.

Authors:  M T Bayliss; P J Roughley
Journal:  Biochem J       Date:  1985-11-15       Impact factor: 3.857

8.  Release of hyaluronan and hyaladherins (aggrecan G1 domain and link proteins) from articular cartilage exposed to ADAMTS-4 (aggrecanase 1) or ADAMTS-5 (aggrecanase 2).

Authors:  Priya S Chockalingam; Weilan Zeng; Elisabeth A Morris; Carl R Flannery
Journal:  Arthritis Rheum       Date:  2004-09

9.  Monoclonal antibodies as probes for determining the microheterogeneity of the link proteins of cartilage proteoglycan.

Authors:  B Caterson; J R Baker; J E Christner; Y Lee; M Lentz
Journal:  J Biol Chem       Date:  1985-09-15       Impact factor: 5.157

10.  Chondrocytes, synoviocytes and dermal fibroblasts all express PH-20, a hyaluronidase active at neutral pH.

Authors:  Hafida El Hajjaji; Ada Asbury Cole; Daniel-Henri Manicourt
Journal:  Arthritis Res Ther       Date:  2005-04-04       Impact factor: 5.156

View more
  12 in total

Review 1.  The pericellular hyaluronan of articular chondrocytes.

Authors:  Warren Knudson; Shinya Ishizuka; Kenya Terabe; Emily B Askew; Cheryl B Knudson
Journal:  Matrix Biol       Date:  2018-02-06       Impact factor: 11.583

2.  Use of cartilage derived from murine induced pluripotent stem cells for osteoarthritis drug screening.

Authors:  Vincent P Willard; Brian O Diekman; Johannah Sanchez-Adams; Nicolas Christoforou; Kam W Leong; Farshid Guilak
Journal:  Arthritis Rheumatol       Date:  2014-11       Impact factor: 10.995

3.  High resistance of the mechanical properties of the chondrocyte pericellular matrix to proteoglycan digestion by chondroitinase, aggrecanase, or hyaluronidase.

Authors:  Rebecca E Wilusz; Farshid Guilak
Journal:  J Mech Behav Biomed Mater       Date:  2013-10-03

4.  CD44 knock-down in bovine and human chondrocytes results in release of bound HYAL2.

Authors:  Daisuke Hida; Ben T Danielson; Cheryl B Knudson; Warren Knudson
Journal:  Matrix Biol       Date:  2015-04-09       Impact factor: 11.583

5.  Hyaluronan synthase 2 (HAS2) overexpression diminishes the procatabolic activity of chondrocytes by a mechanism independent of extracellular hyaluronan.

Authors:  Shinya Ishizuka; Saho Tsuchiya; Yoshifumi Ohashi; Kenya Terabe; Emily B Askew; Naoko Ishizuka; Cheryl B Knudson; Warren Knudson
Journal:  J Biol Chem       Date:  2019-07-03       Impact factor: 5.157

6.  Cytokine-induced MMP13 Expression in Human Chondrocytes Is Dependent on Activating Transcription Factor 3 (ATF3) Regulation.

Authors:  Chun Ming Chan; Christopher D Macdonald; Gary J Litherland; David J Wilkinson; Andrew Skelton; G Nicholas Europe-Finner; Andrew D Rowan
Journal:  J Biol Chem       Date:  2016-12-12       Impact factor: 5.157

7.  Aggrecan heterogeneity in articular cartilage from patients with osteoarthritis.

Authors:  John S Mort; Yeqing Geng; William D Fisher; Peter J Roughley
Journal:  BMC Musculoskelet Disord       Date:  2016-02-18       Impact factor: 2.362

8.  Long non-coding XIST raises methylation of TIMP-3 promoter to regulate collagen degradation in osteoarthritic chondrocytes after tibial plateau fracture.

Authors:  Hongwei Chen; Shengdi Yang; Ruyi Shao
Journal:  Arthritis Res Ther       Date:  2019-12-09       Impact factor: 5.156

9.  Evidence for lysosomal exocytosis and release of aggrecan-degrading hydrolases from hypertrophic chondrocytes, in vitro and in vivo.

Authors:  Edward R Bastow; Karena Last; Sue Golub; Jennifer L Stow; Amanda C Stanley; Amanda J Fosang
Journal:  Biol Open       Date:  2012-02-10       Impact factor: 2.422

10.  VIP and CRF reduce ADAMTS expression and function in osteoarthritis synovial fibroblasts.

Authors:  Selene Pérez-García; Mar Carrión; Irene Gutiérrez-Cañas; Isidoro González-Álvaro; Rosa P Gomariz; Yasmina Juarranz
Journal:  J Cell Mol Med       Date:  2016-01-28       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.